Arca
Skip to content

Break Wave

Lithotriptor, Extracorporeal Shock-Wave, Urological. 510(k) K252913, from Sonomotion, Inc. (San Mateo, CA). Product code LNS, class 2.

As of Nov 16, 2026, K252913 is an FDA 510(k) held by Sonomotion, Inc., substantially equivalent on Jan 12, 2026 after 122 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jan 12, 2026
  • Review time: 122 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Break Wave device is intended to fragment urinary stones in the kidney (renal pelvis and renal calyces) and ureter (upper and lower ureter).

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

1 later 510(k) summary names this device as a predicate
  • Break WaveK261086 · Sonomotion, Inc. · Apr 29, 2026

Other LNS Clearances

The newest 510(k)s for the same product code; their median review was 267 days; see every LNS device

Record

Type
Traditional
Received
Sep 12, 2025
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.5990

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.